About Repros
Company Overview
Board of Directors and Management
Pipeline
Proellex
®
Anemia Associated with Uterine Fibroids
Uterine Fibroids
Endometriosis
Publications
Androxal
®
Male Fertility Maintenance/Improvement
Metabolic Syndrome
Publications
Clinical Trials
Proellex® Uterine Fibroids (ZPU-301)
Proellex® Endometriosis (ZPE-201)
Proellex® PK Bridging (ZP-002)
Proellex® Safety and PK (ZP-003)
Androxal® Secondary Hypogonadism (ZA-201)
Investors & Media
Events, Presentations and Webcasts
Repros in the News
Major Holders
Analyst Coverage
SEC Filings
Corporate Governance
Contact Us
Investors & Media
Events, Presentations and Webcasts
Repros in the News
Major Holders
Analyst Coverage
SEC Filings
Corporate Governance
Repros Therapeutics Inc.
$9.80 (+0.07)
Nasdaq: RPRX
Repros Shareholder Update Conference Call
May 12, 2008 @ 12:00 p.m. Central
Terms of Use
© Repros Therapeutics Inc. All rights reserved.
2408 Timberloch Place, B-7
The Woodlands, Texas 77380
281-719-3400
281-719-3446 fax